Jasper Therapeutics, Inc. (JSPR) — research page
US · us-cm-kg/NASDAQ/JSPR · as of 2026-11-08
Identity and listing
The issuer is Jasper Therapeutics, Inc., listed on NASDAQ under ticker JSPR, ISIN US4718712023. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Jasper Therapeutics, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | JSPR | source · 2026-11-08 |
| ISIN | US4718712023 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 70 filings in the window 2025-11-08 to 2026-11-08, across 49 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-04, four days before the record date of 2026-11-08, and is a corporate_news filing. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4,359 issuers. In the sector the median cadence gap is 5.5 days, the median filings count is 65.5, and the median latency is 4.0 days across 176 issuers. The issuer's 70 filings are above the NASDAQ median of 52 and above the sector median of 65.5. Its cadence gap of 4.0 days is below the NASDAQ median of 6.0 days and below the sector median of 5.5 days. Its latency of 4 days is below the NASDAQ median of 5.0 days and equal to the sector median of 4.0 days. By type the window holds 2 ad_hoc, 8 agm_egm, 10 corporate_news, 3 director_change, 15 directors_dealings, 2 halt_suspension, 1 prospectus, 18 regulatory_filing, 9 results, and 2 takeover filings.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 70 | 4 | 4 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-04 | corporate_news | 8-K | 8-K — CURRENT REPORT (items 3.03,5.03,7.01,9.01) |
| 2026-10-28 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-10-23 | takeover | SC TO-I/A | SC TO-I/A — AMENDMENT NO. 1 TO FORM SC TO-I |
| 2026-10-19 | agm_egm | DEF 14A | DEF 14A — PROXY STATEMENT |
| 2026-10-15 | corporate_news | 8-K | 8-K — CURRENT REPORT (items 8.01,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is PricewaterhouseCoopers LLP, located in San Jose, California. The record holds no auditor changes.
Events and halts
The record holds one lifecycle line: a delisting dated 2026-09-24. No listing, name change or segment move is on the record, and the domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read. The count is 0.
Open research
No openly published research notes were found. The count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001788028.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/JSPR (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1788028/000121390026036426/ea0282128-10k_jasper.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/JSPR (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US4718712023"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9875571e422cbfb5.